参考文献/References:
[1] Feng H,Wang J,Jiang H,et al.β-Elemene selectively inhibits the proliferation of glioma stem-like cells through the downregulation of notch1[J].Stem Cells Transl Med,2017,6(3):830-839.
[2] Wang B,Wang K,Jin T,et al.NCK1-AS1 enhances glioma cell proliferation,radioresistance and chemoresistance via miR-22-3p/IGF1R ceRNA pathway[J].Biomed Pharmacother,2020,129(5):110395-110405.
[3] Kaya B,Goceri E,Becker A,et al.Automated fluorescent miscroscopic image analysis of PTBP1 expression in glioma[J].PLoS One,2017,12(3):e0170991.
[4] Serventi J,Behr J.Surgery and evidence-based treatments in patients with newly diagnosed high-grade glioma[J].Semin Oncol Nurs,2018,34(5):443-453.
[5] Zhang L,Yang HC,Zhang WB,et al.Clk1-regulated aerobic glycolysis is involved in glioma chemoresistance[J].J Neurochem,2017,142(4):574-588.
[6] Karachi A,Dastmalchi F,Mitchell DA,et al.Temozolomide for immunomodulation in the treatment of glioblastoma[J].Neuro Oncol,2018,20(12):1566-1572.
[7] Zhang Y,Zhang J,Mao L,et al.Long noncoding RNA HCG11 inhibited growth and invasion in cervical cancer by sponging miR-942-5p and targeting GFI1[J].Cancer Med,2020,9(19):7062-7071.
[8] Xue HX,Li HF,Wang T,et al.LncRNA HCG11 suppresses laryngeal carcinoma cells progression via sponging miR-4469/APOM axis[J].Eur Rev Med Pharmacol Sci,2020,24(6):3174-3182.
[9] Zhang LN,Cao YF,Kou XN,et al.Long non-coding RNA HCG11 suppresses the growth of glioma by cooperating with the miR-4425/MTA3 axis[J].J Gene Med,2019,21(4):e3074.
[10]Li B,Zhao HK,Song JM,et al.LINC00174 down-regulation decreases chemoresistance to temozolomide in human glioma cells by regulating miR-138-5p/SOX9 axis[J].Hum Cell,2020,33(1):159-174.
[11]Fan G,Jiao J,Shen F,et al.Long non-coding RNA HCG11 sponging miR-522-3p inhibits the tumorigenesis of non-small cell lung cancer by upregulating SOCS5[J].Thoracic Cancer,2020,11(10):2877-2886.
[12]Zhang H,Huang H,Xu X,et al.LncRNA HCG11 promotes proliferation and migration in gastric cancer via targeting miR-1276/CTNNB1 and activating Wnt signaling pathway[J].Cancer Cell Int,2019,19(1):350-362.
[13]Liu K,Tsung K,Attenello FJ.Characterizing cell stress and GRP78 in glioma to enhance tumor treatment[J].Front Oncol,2020,10(1):608911-608928.
[14]Yang J,Yu D,Liu X,et al.LINC00641/miR-4262/NRGN axis confines cell proliferation in glioma[J].Cancer Biol Ther,2020,21(8):758-766.
[15]Liu ZZ,Tian YF,Wu H,et al.LncRNA H19 promotes glioma angiogenesis through miR-138/HIF-1α/VEGF axis[J].Neoplasma,2020,67(1):111-118.
[16]Yu MJ,Yi BL,Zhou W,et al.Linc00475 promotes the progression of glioma by regulating the miR-141-3p/YAP1 axis[J].J Cell Mol Med,2021,25(1):463-472.
[17]Park JE,Kim HW,Yun SH,et al.Ginsenoside Rh2 upregulates long noncoding RNA STXBP5-AS1 to sponge microRNA-4425 in suppressing breast cancer cell proliferation[J].J Ginseng Res,2021,45(6):754-762.
[18]Nakae A,Kodama M,Okamoto T,et al.Ubiquitin specific peptidase 32 acts as an oncogene in epithelial ovarian cancer by deubiquitylating farnesyl-diphosphate farnesyltransferase 1[J].Biochem Biophys Res Commun,2021,552(1):120-127.
[19]Weng ML,Chen WK,Chen XY,et al.Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression[J].Nat Commun,2020,11(1):1869.
[20]Lu J,Zhou Y,Zheng X,et al.20(S)-Rg3 upregulates FDFT1 via reducing miR-4425 to inhibit ovarian cancer progression[J].Arch Biochem Biophys,2020,693(1):108569-108579.